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Continuous Infusion of Nafcillin for Sternal Osteomyelitis in an Infant 
After Cardiac Surgery
Chad A. Knoderer, PharmD,1,2,3 Jennifer L. Morris, PharmD,2,4 and Elaine G. Cox, MD3
1Department of Pharmacy Practice, College of Pharmacy and Health Sciences, Butler University, Indianapolis, Indi-
ana, 2Department of Pharmacy, Riley Hospital for Children, Clarian Health, Indianapolis, Indiana, 3Department of 
Pediatrics, Ryan White Center for Pediatric Infectious Disease, Indiana University School of Medicine, Indianapolis, 
Indiana, and 4Department of Pharmacy Practice, Purdue University School of Pharmacy and Pharmaceutical Sciences, 
Indianapolis, Indiana
We.report.the.use.of.the.continuous.infusion.of.nafcillin.for.the.treatment.of.an.infant.who.had.methicillin-
susceptible.Staphylococcus aureus sternal.osteomyelitis.not.responsive.to.traditional.nafcillin.dosing. The.
patient.was.successfully.treated.with.surgical.debridement.and.the.continuous.infusion.of.nafcillin..To.our.
knowledge,.this.is.the.first.report.describing.the.successful.use.of.the.continuous.infusion.of.nafcillin.to.treat.
an.infant.who.had.sternal.osteomyelitis.after.cardiac.surgery..
KEYWORDS.congenital.heart.disease,.continuous.infusion,.nafcillin,.sternal.wound.infection.
J.Pediatr.Pharmacol.Ther 2010;15:49–54
ABBREVIATIONS.ASD,.atrial.septal.defect;.CoA,.coarctation.
of.the.aorta;.CPB,.cardiopulmonary.bypass;.DOL,.day.of.life;.
IV,.intravenous;.MIC,.minimum.inhibitory.concentration;.
MSSA,.methicillin-susceptible.Staphylococcus aureus;.VSD,.
ventricular.septal.defect;.WBC,.white.blood.cell.
BACKGROUND
Surgical site infections account for approxi-
mately 16% of hospital-acquired infections and 
remain a concern in the treatment of children 
undergoing surgery for the repair of congenital 
heart disease.1 Sternal wound infections occur 
in 5% of children who have undergone median 
sternotomy. For children who have undergone 
cardiac surgery, incidence of such infections is 3% 
for superficial sternal infections, 2% for deep ster-
nal infections, and 0.04%-3.9% for mediastinitis.2-5 
Surgical debridement and prolonged durations 
of the intravenous (IV) administration of antibi-
otics are the mainstays of treatment. Because of 
the organisms that commonly precipitate medi-
astinal infections, antistaphylococcal or broad 
spectrum beta-lactam antibiotics are often used 
to treat these infections.3 In contrast with a similar 
regimen applied in the adult population, there 
are few reports of the administration of beta-
lactam antibiotics via continuous IV infusion in 
children and in practice is rarely used.6-8 To our 
knowledge, our report is the first published case 
of a patient treated with a continuous infusion 
of nafcillin for sternal osteomyelitis after surgery 
for congenital heart disease.
CASE REPORT
A 12-day-old, full-term, male infant with con-
genital heart disease that had features consistent 
with Shone’s complex—coarctation of the aorta 
(CoA), a hypoplastic and bicuspid aortic valve, a 
mildly hypoplastic aortic arch, a secundum atrial 
septal defect (ASD), and a paramembranous 
ventricular septal defect (VSD)—was admitted 
for increased work of breathing, shortness of 
breath, and diaphoresis with feeding. His CoA 
was surgically repaired on the 15th day of life 
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(DOL), and he received an extended end-to-end 
anastomosis through a thoracotomy incision. 
He was admitted to the pediatric intensive care 
unit for postoperative care. On the second post-
operative day (DOL 17), the patient was begun 
on inotropic support for hemodynamic instabil-
ity; vancomycin (30 mg/kg/d divided every 12 
hours) and piperacillin-tazobactam (300 mg/
kg/d divided every 8 hours) were initiated to 
rule out sepsis. The patient was afebrile at this 
time, and his white blood cell (WBC) count was 
normal. Blood and urine cultures tested negative 
for the presence of bacteria, and the antibiotics 
were discontinued after 48 hours. Over the next 
several days, the patient continued to exhibit 
signs of heart failure and ultimately did not wean 
from mechanical ventilation. Echocardiogram 
findings showed significant left-to-right shunt-
ing through the ASD and VSD. The patient was 
taken to surgery on DOL 28 for repair of his 
ASD and VSD. Cardiopulmonary bypass (CPB) 
and moderate hypothermia were required for 
surgical repair. 
After ASD and VSD repair, the infant re-
mained mechanically ventilated in the pedi-
atric intensive care unit. The patient received 
24 hours of postoperative cefuroxime sodium 
prophylaxis. On the fourth postoperative day 
(DOL 32), the patient’s WBC count increased to 
23.9 × 103/mm3 from 11.5 × 103/mm3, with a dif-
ferential of 77% neutrophils and 17% bands. The 
platelet count decreased to 61 × 103/mm3 from 
Table. Laboratory.Parameters.After.ASD.and.VSD.Repair
DOL POD ASD/VSD
WBC Count*
(N/B)†
Platelet Count‡ Culture Analysis Results
31 3 11.5(58/6) 106 N/A
32 4 23.9(77/17) 61
Blood,.MSSA.(+)§
Chest.tube.fluid,.MSSA.(+)
33 5 13.3(52/33) 48 Blood,.MSSA.(+)
34 6 9.4(79/14) 25 Blood,.no.growth
35 7 6.1(80/0) 39 N/A
36 8 3.4(61/0) 64 no.growth
37 9 6.5(77/0) 79 N/A
38 10 7.4(29/18) 167 N/A
39 11 11.1(74/0) 174 no.growth
40 12 20.2(66/16) 174 N/A
41 13 16.9(88/0) 176 N/A
42 14¶ 16.9(90/0) 180
Bone,.MSSA.(+)
Wound,.MSSA.(+)
43 15 13(85/0) 174 N/A
ASD, atrial septal defect; B, bands; DOL, day of life; MSSA, methicillin-susceptible Staphylococcus aureus; N, neutrophils; N/A , not applicable 
because no specimen taken, POD, postoperative day; VSD, ventricular septal defect; WBC, white blood cells.
Ý Calculated as No. x 103/mm3
† Percentage of neutrophils/percentage of bands
† Calculated as No. x 103/mm3
§ (+) Symbol indicates positive
¶ Continuous infusion of nafcillin initiated
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106 × 103/mm3 (Table). Chest tube (placed dur-
ing ASD/VSD repair) drainage at that time was 
observed to be milky in appearance, although 
there was not an increase in output. Analysis of 
this fluid revealed a triglyceride concentration 
of 85 mg/dL, and chylothorax was ruled out.9,10 
Because the patient was afebrile, antibiotics 
were not started, but blood and urine cultures 
were obtained. On DOL 33, the microbiologi-
cal analysis showed that 3 of 4 bottles of blood 
from the previous day had tested positive for 
Gram-positive cocci, which were subsequently 
identified as methicillin-susceptible Staphylococ-
cus aureus (MSSA). The MSSA was resistant to 
penicillin but retained susceptibility to oxacillin 
with a minimum inhibitory concentration (MIC) 
of 0.5 mg/L. Additional blood and urine cultures 
were obtained. There was a moderate amount of 
milky-appearing drainage from the chest tube 
had a strong odor and was also sent for culture. 
Vancomycin (30 mg/kg/d divided every 12 
hours), gentamicin (4.3 mg/kg every 24 hours), 
and piperacillin (250 mg/kg/d divided every 8 
hours) were initiated after the new cultures were 
obtained. The second set of blood cultures and 
cultures of the chest tube drainage from DOL 
33 also tested positive for MSSA. Vancomycin 
and piperacillin were discontinued on DOL 
35, and nafcillin was initiated at 170 mg/kg/d 
divided every 6 hours. The maximum dose of 
nafcillin was not initiated because of concerns 
for potential hematologic and hepatic toxici-
ties. Gentamicin was continued as a 4.3 mg/kg 
dose every 24 hours. Serum concentrations of 
gentamicin were obtained weekly and were 
at so-called “therapeutic values” for low-dose 
gentamicin MSSA therapy.
Over the next 2 days, the infant remained 
afebrile and had a decreasing WBC count. The 
chest tube output was thick and brownish. The 
patient again did not wean to extubation from 
mechanical ventilation on DOL 39. Erythema 
was observed on DOL 41, spreading out from the 
sternal wound with an area of fluctuance under 
the dressing. The sternal incision had reddened, 
and it had a dime-sized, fluid pocket on the up-
per third of the incision site. The patient went 
for mediastinal exploration and debridement 
the next day. Intraoperative findings showed 
purulent material beneath the skin and anterior 
to the sternum and it was exposed to the lower 
half of the sternum. The wound infection also ap-
peared to tract down toward the chest tube site. 
The lowermost sternal wire was removed, as it 
was partially loose, along with a small bone flap 
that appeared to be partially disengaged from the 
rest of the sternum. The purulent material and 
bone fragment were sent for culture; they tested 
positive for MSSA. 
On the basis of the positive results for the 
wound culture and intraoperative observations 
from the mediastinal exploration, on DOL 42, 
intermittent administration of nafcillin was 
stopped, and continuous infusion dosing was 
started to optimize the drug’s pharmacodynamic 
profile. The nafcillin was dosed to provide 185 
mg/kg/d, delivered as a continuous IV infusion. 
This dosage was approximately the same total 
daily dose that was being administered with in-
termittent dosing. Over the subsequent days, the 
patient’s condition was stable, and the incision 
had no signs of infection. An additional wound 
culture obtained on DOL 49 (7 days after surgical 
debridement) was negative for the presence of 
bacteria. The patient was treated for an additional 
12 days with gentamicin (26 days total) and 35 
days of continuous infusion nafcillin (49 days 
total duration). No additional signs of wound 
infection were present.
The continuous infusion of nafcillin was well 
tolerated. We observed no clinically significant 
changes in the patient’s hepatic or hematologic 
laboratory values. Although the patient had a 
maculopapular rash 2 days after the initiation 
of the continuous infusion of nafcillin, the rash 
appeared to be caused by external contact, and 
it subsided over the next several days without 
discontinuation of nafcillin. 
The patient had one subsequent episode of 
bacteremia that occurred 14 days after discon-
tinuation of nafcillin. Blood cultures from DOL 
97 and 100 tested positive for coagulase-negative 
staphylococci, which were methicillin-resistant; 
the patient received treatment with vancomycin 
for 10 days. Although the patient had received 
antibiotics on several occasions after the discon-
tinuation of nafcillin, no cultures yielded reoc-
currence of MSSA. 
The patient continued with a prolonged hospi-
talization because of secondary developmental 
and respiratory issues. He continued to require 
mechanical ventilation and underwent a trache-
ostomy on DOL 112. The patient was discharged 
home on DOL 284 on a laptop ventilator. 
Continuous Infusion of Nafcillin in an Infant
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DISCUSSION
Surgical site infections remain a serious and 
frequent complication of cardiac surgery. Of 
particular concern are deep sternal wound infec-
tions and mediastinitis that can lead to significant 
morbidity and mortality. The incidence of sternal 
wound infections has been shown to be greater in 
neonates (5.5%) than in older children (0.5%) and 
has been associated with increased morbidity and 
mortality in neonates.11 Incisional cellulitis and 
fever are common signs of sternal wound infec-
tion in children, and in multiple series, Staphylo-
coccus aureus and Staphylococcus epidermidis were 
the most common pathogens.3-5,11-14
Risk factors for sternal wound infection in 
children who have undergone cardiac surgery 
include younger age, prolonged ventilation, 
length of surgery, duration of central venous 
catheterization, and deep hypothermic circula-
tory arrest.4,14,15 Our patient had multiple risk fac-
tors for infection. After the initial CoA repair, our 
patient underwent surgical repair of his ASD and 
VSD and had progressive heart failure in addition 
to a prolonged need for mechanical ventilation. 
Repair of the ASD and VSD required CPB with 
moderate hypothermia. The use of CPB with 
hypothermia may result in decreased immune 
function postoperatively. Decreased immune 
function may also occur because of prolonged 
periods of diminished cardiac output coupled 
with the young age of the patient.16 
Treatment for deep sternal wound infection, 
mediastinitis, and sternal osteomyelitis include 
both surgical debridement and prolonged anti-
biotic therapy.11-13,17-19 Optimization of antibiotic 
dosing is critical. Nafcillin, a beta-lactam antibi-
otic, exhibits time-dependent bacterial killing; 
the amount of time the drug serum concentra-
tion is above the MIC is the main predictor of 
efficacy.20,21 Bacteria regrowth can occur when the 
drug serum concentration falls below the MIC.21 
In children, nafcillin is typically dosed every six 
hours, but this empiric dosing strategy may not 
optimize the duration of drug exposure at the 
source of infection in cases of deep sternal wound 
infection such as osteomyelitis. Rather, relative 
to the MIC, continuous infusion of nafcillin—as 
with other beta-lactam antibiotics—may more 
reliably provide adequate drug concentrations 
at the site of infection.21,22 Although optimiza-
tion of antibiotic dosing is critical in patients 
with surgical wound infections, no reports have 
been published about the continuous infusion 
of antibiotics in children with secondary sternal 
osteomyelitis.
Continuous infusion of beta-lactam antibiotics 
such as nafcillin, piperacillin-tazobactam, and 
ceftazidime is used in adult patients to optimize 
each drug’s pharmacodynamic profile, to take 
advantage of their convenience, and to reduce 
the consumption of health care resources.20,22,23 
Compared with intermittent dosing, this admin-
istration method has been shown to lead to cost 
reductions.24,25 Reports of the continuous infu-
sion of nafcillin in children are unavailable, but 
the medical literature regarding this population 
includes a few reports of other beta-lactam anti-
biotics and vancomycin being dosed as continu-
ous infusions for indications other than sternal 
osteomyelitis.6-8 Dalle and colleagues studied the 
pharmacokinetic profile of ceftazidime continu-
ously administered by IV in 20 febrile children 
(median age, 5.4 years) who had neutropenia.7 
Administration of a 65 mg/kg loading dose and 
continuous infusion of ceftazidime (200 mg/
kg/d) resulted in mean serum concentrations 
of 30.4-33 mg/L at 23-43 hours after initiation of 
the infusion.7 Authors of another study reported 
the efficacy of the continuous infusion of ceftazi-
dime in 14 children (mean age, 12.6 years) who 
had cystic fibrosis.8 Compared with ceftazidime 
administered at 200 mg/kg/day 3 times a day, 
the continuous infusion of ceftazidime at 100 
mg/kg/d provided similar effects on pulmonary, 
inflammatory, and nutritional status markers.8 
Continuous infusions were well tolerated in 
both studies.7,8 Vancomycin, cefuroxime, and 
piperacillin-tazobactam also have been admin-
istered successfully as continuous infusions in 
13 children, aged 2 months to 14 years, who 
were treated for persistent, central intravenous 
catheter-related infections due to Gram-positive 
organisms.6 
After multiple cultures tested positive for 
MSSA, including a positive result for a wound 
specimen that was taken while the patient was 
receiving intermittent administration of nafcillin, 
the continuous infusion of nafcillin was initiated 
to optimize our patient’s nafcillin exposure. Al-
though the medical literature includes reports of 
children being treated with continuous infusions 
of other beta-lactam antibiotics or vancomycin, 
which have shown activity against MSSA, we 
Knoderer CA, et al
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elected to use nafcillin for our patient because of 
the narrow spectrum of bacterial coverage and 
the drug’s effectiveness against MSSA. We con-
sidered switching to an intermittent dosing regi-
men of every 4 hours rather than the continuous 
infusion of nafcillin. However, given the nursing 
and pharmacy resources required for intermittent 
administration versus continuous infusion and 
the anticipated prolonged duration of therapy, 
we elected to administer nafcillin as a continuous 
infusion. One bag containing a 24-hour supply 
(nafcillin 24 mg/mL in 5% dextrose) was com-
pounded daily by the inpatient pharmacy, and 
the nursing staff changed the infusion once per 
day to limit IV line interruptions. The total daily 
dose of nafcillin was divided by 24 hours and 
administered as a continuous infusion. Specific 
nafcillin concentrations were not targeted. The 
benefit of such concentrations is questionable 
since our patient’s infection involved primary 
bone and was not a blood stream infection. Also, 
our laboratory was not able to analyze serum naf-
cillin concentrations; hence, samples would have 
to be sent to a referral laboratory. The significant 
delay in acquiring results diminished the utility 
of trying to active certain concentrations.
CONCLUSIONS
To our knowledge, our case is the first report 
of the use of a continuous infusion of nafcillin in 
an infant who had sternal osteomyelitis after car-
diovascular surgery. The diagnosis of the sternal 
wound infection was confirmed using laboratory 
and clinical criteria. The infection did not respond 
to initial antimicrobial therapy administered 
via a traditional dosing strategy. After receiving 
surgical debridement and continuous infusion 
nafcillin, the patient was successfully treated. 
DISCLOSURE.The.authors.declare.no.conflicts.or.finan-
cial.interests.in.any.product.or.service.mentioned.in.the.
manuscript,. including.grants,.equipment,.medications,.
employment,.gifts,.and.honoraria.
REFERENCES
1.  Bratzler DW, Houck PM. Antimicrobial 
prophylaxis for surgery: an advisory state-
ment from the National Surgical Infection 
Prevention Project. Am J Surg 2005;189:395-
404.
2.  Edwards MS, Baker CJ. Median sternotomy 
wound infections in children. Pediatr Infect 
Dis J 1983;2:105-109.
3.  Long CB, Shah SS, Lautenbach E, et al. 
Postoperative mediastinitis in children: 
epidemiology, microbiology and risk fac-
tors for Gram-negative pathogens. Pediatr 
Infect Dis J 2005;24:315-319.
4.  Mehta PA, Cunningham CK, Colella CB, 
et al. Risk factors for sternal wound and 
other infections in pediatric cardiac surgery 
patients. Pediatr Infect Dis J 2000;19:1000-
1004.
5.  Tabbutt S, Duncan BW, McLaughlin D, et 
al. Delayed sternal closure after cardiac op-
erations in a pediatric population. J Thorac 
Cardiovasc Surg 1997;113:886-893.
6.  Giacchino M, Bezzio S, Chiapello N, et 
al. Continuous antibiotic infusion for 
salvage therapy of partially implanted 
central venous catheter tunnel infections 
due to staphylococci. Pediatr Blood Can-
cer.2007;49:1010-1012.
7.  Dalle JH, Gnansounou M, Husson MO, 
Lambilliotte A, Mazingue F, Nelken B. 
Continuous infusion of ceftazidime in the 
empiric treatment of febrile neutropenic 
children with cancer. J Pediatr Hematol 
Oncol 2002;24:714-716.
8.  Rappaz I, Decosterd LA, Bille J, Pilet M, 
Bélaz N, Roulet M. Continuous infusion 
of ceftazidime with a portable pump is 
as effective as thrice-a-day bolus in cystic 
fibrosis children. Eur J Pediatr 2000;159:919-
925.
9.  Beghetti M, La Scala G, Belli D, et al. Etiol-
ogy and management of pediatric chylo-
thorax. J Pediatr 2000;136:653-658.
10.  Buttiker V, Fanconi S, Burger R. Chylotho-
rax in children: guidelines for diagnosis and 
management. Chest 1999;116:682-687.
11.  Erez E, Katz M, Sharoni E, et al. Pectoralis 
major muscle flap for deep sternal wound 
infection in neonates. Ann Thorac Surg 
2000;69:572-577.
12.  Tortoriello TA, Friedman JD, McKenzie ED, 
et al. Mediastinitis after pediatric cardiac 
surgery: a 15-year experience at a single 
institution. Ann Thorac Surg 2003;76:1655-
1660.
Continuous Infusion of Nafcillin in an Infant
JPPT
54 J Pediatr Pharmacol Ther 2010 Vol. 15 No. 1 • www.jppt.org
13.  Kearns B, Sabella C, Mee RB, et al. Sternal 
wound and mediastinal infections in in-
fants with congenital heart disease. Cardiol 
Young 1999;9:280-284.
14.  Allpress AL, Rosenthal GL, Goodrich KM, 
et al. Risk factors for surgical site infections 
after pediatric cardiovascular surgery. Pe-
diatr Infect Dis J 2004;23:231-234.
15.  McAnally HB, Cutter GR, Ruttenber AJ, et 
al. Hypothermia as a risk factor for pedi-
atric cardiothoracic surgical site infection. 
Pediatr Infect Dis J 2001;20:459-462.
16.  Niederhäuser U, Vogt M, Vogt P, et al. 
Cardiac surgery in a high-risk group of pa-
tients: is prolonged postoperative antibiotic 
prophylaxis effective? J Thorac Cardiovasc 
Surg 1997;114:162-168.
17.  Ohye RG, Maniker RB, Graves HL, et al. 
Primary closure for postoperative medias-
tinitis in children. J Thorac Cardiovasc Surg 
2004;128:480-486.
18.  Kara A, Tezer H, Devrim I, et al. Primary 
sternal osteomyelitis in a healthy child due 
to community-acquired methicillin-resis-
tant Staphylococcus aureus and literature 
review. Scand J Infect Dis 2007;39:469-472.
19.  Upadhyaya M, Keil A, Thonell S, et al. 
Primary sternal osteomyelitis: a case series 
and review of the literature. J Pediatr Surg 
2005;40:1623-1627.
20.  Turnidge JD. The pharmacodynamics of 
beta-lactams. Clin Infect Dis 1998;27:10-22.
21.  Craig WA. Pharmacokinetic/pharmacody-
namic parameters: rationale for antibacte-
rial dosing of mice and men. Clin Infect Dis 
1998;26:1-10.
22.  Craig WA, Ebert SC. Continuous infusion of 
beta-lactam antibiotics. Antimicrob Agents 
Chemother 1992;36:2577-2583.
23.  Mouton JW, Vinks AA. Continuous infu-
sion of beta-lactams. Curr Opin Crit Care 
2007;13:598-606.
24.  Florea NR, Kotapati S, Kuti JL, et al. Cost 
analysis of continuous versus intermittent 
infusion of piperacillin-tazobactam: a time-
motion study. Am J Health-Syst Pharm 
2003;60:2321-2317.
25.  Kotapati S, Kuti JL, Geissler EC, et al. The 
clinical and economic benefits of admin-
istering piperacillin-tazobactam by con-
tinuous infusion. Intensive Crit Care Nurs 
2005;21:87-93.
Knoderer CA, et al
